RESUMEN
OBJECTIVES: To estimate vertical HIV transmission rate in a capital city of the Midwest region of Brazil and describe the factors related to transmission. METHODS: A descriptive epidemiological study based on the analysis of secondary data from the Notifiable Diseases Information System (SINAN). The analysis considered all HIV-infected pregnant women with delivery in Campo Grande-MS in the years 2007-2013 and their HIV-exposed infants. RESULTS: A total of 218 births of 176 HIV-infected pregnant women were identified during the study period, of which 187 infants were exposed and uninfected, 19 seroconverted, and 12 were still inconclusive in July 2015. Therefore, the overall vertical HIV transmission rate in the period was 8.7%. Most (71.6%) of HIV-infected pregnant women were less than 30 years at delivery, housewives (63.6%) and studied up to primary level (61.9%). Prenatal information was described in 75.3% of the notification forms and approximately 80% of pregnant women received antiretroviral prophylaxis. Among infants, 86.2% received prophylaxis, but little more than half received it during the whole period recommended by the Brazilian Ministry of Health. Among the exposed children, 11.3% were breastfed. CONCLUSION: The vertical HIV transmission rate has increased over the years and the recommended interventions have not been fully adopted. HIV-infected pregnant women need adequate prophylactic measures in prenatal, intrapartum and postpartum, requiring greater integration among health professionals.
Asunto(s)
Infecciones por VIH/transmisión , Transmisión Vertical de Enfermedad Infecciosa/estadística & datos numéricos , Complicaciones Infecciosas del Embarazo/epidemiología , Adulto , Factores de Edad , Terapia Antirretroviral Altamente Activa , Western Blotting , Brasil/epidemiología , Lactancia Materna , Cesárea , Escolaridad , Ensayo de Inmunoadsorción Enzimática , Femenino , Técnica del Anticuerpo Fluorescente Indirecta , Infecciones por VIH/tratamiento farmacológico , Humanos , Recién Nacido , Masculino , Parto Normal , Embarazo , Factores de Riesgo , Adulto JovenRESUMEN
ABSTRACT The HIV-1 initial viral infection may present diverse clinical and laboratory course and lead to rapid, intermediate, or long-term progression. Among the group of non-progressors, the elite controllers are those who control the infection most effectively, in the absence of antiretroviral therapy (ART). In this paper, the TH1, TH2 and TH17 cytokines profiles are described, as well as clinical and laboratory aspects of an HIV-infected patient with undetectable viral load without antiretroviral therapy. Production of IL-6, IL-10, TNF-α, IFN-γ, and IL-17 was detected; in contrast IL-4 was identified. Host-related factors could help explain such a level of infection control, namely the differentiated modulation of the cellular immune response and a non-polarized cytokine response of the TH1 and TH2 profiles.
Asunto(s)
Humanos , Femenino , Adulto , Infecciones por VIH/inmunología , Citocinas/inmunología , VIH-1 , Sobrevivientes de VIH a Largo Plazo , Linfocitos T CD4-Positivos/inmunología , Infecciones por VIH/sangre , Infecciones por VIH/virología , Células Th2/inmunología , Células TH1/inmunología , Linfocitos T CD8-positivos/inmunología , Carga Viral , Terapia Antirretroviral Altamente Activa , Inmunidad Celular/inmunologíaRESUMEN
The HIV-1 initial viral infection may present diverse clinical and laboratory course and lead to rapid, intermediate, or long-term progression. Among the group of non-progressors, the elite controllers are those who control the infection most effectively, in the absence of antiretroviral therapy (ART). In this paper, the TH1, TH2 and TH17 cytokines profiles are described, as well as clinical and laboratory aspects of an HIV-infected patient with undetectable viral load without antiretroviral therapy. Production of IL-6, IL-10, TNF-α, IFN-γ, and IL-17 was detected; in contrast IL-4 was identified. Host-related factors could help explain such a level of infection control, namely the differentiated modulation of the cellular immune response and a non-polarized cytokine response of the TH1 and TH2 profiles.
Asunto(s)
Citocinas/inmunología , Infecciones por VIH/inmunología , Sobrevivientes de VIH a Largo Plazo , VIH-1 , Adulto , Terapia Antirretroviral Altamente Activa , Linfocitos T CD4-Positivos/inmunología , Linfocitos T CD8-positivos/inmunología , Femenino , Infecciones por VIH/sangre , Infecciones por VIH/virología , Humanos , Inmunidad Celular/inmunología , Células TH1/inmunología , Células Th2/inmunología , Carga ViralRESUMEN
We report on the first isolation of dengue virus serotype 4 (DENV-4) in the State of Mato Grosso do Sul, Brazil, in February, 2012. The cases were isolated in the city of Campo Grande, the state capital, and presented the classic signs and symptoms of dengue fever. DENV-4 was primarily identified through viral isolation in C6/36 clone lineage of Aedes albopictus cells; followed by indirect immunofluorescence, using type-specific monoclonal antibodies. The results were subsequently confirmed by Nested RT-PCR tests. The first description of the introduction of DENV-4 in a state whose population is susceptible to this serotype and the circulation of three other serotypes in the area is cause for concern due to the increased possibility of severe and lethal cases of the disease, and of huge epidemics.
Asunto(s)
Virus del Dengue/genética , Dengue/virología , Adolescente , Adulto , Anciano , Brasil/epidemiología , Dengue/epidemiología , Virus del Dengue/aislamiento & purificación , Femenino , Humanos , Masculino , Persona de Mediana Edad , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Adulto JovenRESUMEN
OBJECTIVES: The goal of the authors was to determine the epidemiological and clinical characteristics of all HIV-positive children and adolescents infected by vertical transmission. METHODS: A descriptive, cross-sectional and retrospective study was conducted that included all HIV-positive patients infected by vertical transmission who attended the referral services of the municipality of Campo Grande from 1993 to 2009, and who used antiretrovirals (ARV). The data were collected from medical records after local institutional review board approval. RESULTS: 78 patients were included, and almost half of the living patients (75) in 2009 were 11-15 years of age. The average age at diagnosis was 38.8 months, treatment was most often initiated from 12 to 35 months of age, and HAART was the most common treatment. Most patients (51.3%) were hospitalised between one and five times, and the first regimen was not associated with hospitalisation (p=0.2). The majority of patients did not exhibit virological suppression at the last examination, and genotyping revealed the presence of resistance mutations. Failure of therapy was often the result of non-adherence to therapy. Five patients died, and the causes of death were pneumonia, sepsis, cerebral cryptococcosis and myocarditis. CONCLUSIONS: Despite the availability of drugs and appropriate laboratory tests, a significant number of paediatric patients were failing ARV therapy due to non-adherence. Further interventions to enhance adherence in this population are needed.
Asunto(s)
Infecciones por VIH/epidemiología , Infecciones por VIH/patología , Transmisión Vertical de Enfermedad Infecciosa , Adolescente , Fármacos Anti-VIH/administración & dosificación , Brasil/epidemiología , Niño , Preescolar , Estudios Transversales , Femenino , Infecciones por VIH/tratamiento farmacológico , Infecciones por VIH/transmisión , Humanos , Lactante , Masculino , Cumplimiento de la Medicación/estadística & datos numéricos , Estudios Retrospectivos , Adulto JovenRESUMEN
In this study, the prevalence of HTLV 1/2 infection among pregnant women in the State of Mato Grosso do Sul was estimated by means of the ELISA, Western Blot and PCR techniques, in blood samples collected by peripheral venous puncture. 116,689 pregnant women were examined and 153 were diagnosed as presenting HTLV 1/2 infection, with prevalence of 0.13%. Among these 153 pregnant women, 133 (86.9%) had type 1 and 20 (11.1%) had type 2; 73.2% were black, brown or indigenous; about 90% performed domestic activities; and 75.8% (116/153) had been to school for seven years or less. The 153 pregnant women had 172 pregnancies during the study period and 164 pregnancies were followed. Out of pregnancies that were followed, 6.7% (11/164) evolved to abortion, 26.8% (41/153) reported previous abortions and 31.7% (13/41) had had more than two abortions. Comorbidities were found in 17% (26/153), among whom 3.3% (5/153) had HIV (p<0.000002). The authors emphasize the importance of identifying pregnant women with HTLV 1/2 infection, as a strategy for disease control and prevention.
Asunto(s)
Infecciones por HTLV-I/epidemiología , Infecciones por HTLV-II/epidemiología , Virus Linfotrópico T Tipo 1 Humano , Virus Linfotrópico T Tipo 2 Humano , Complicaciones Infecciosas del Embarazo/epidemiología , Adolescente , Adulto , Western Blotting , Brasil/epidemiología , Ensayo de Inmunoadsorción Enzimática , Femenino , Anticuerpos Anti-HTLV-I/sangre , Infecciones por HTLV-I/diagnóstico , Anticuerpos Anti-HTLV-II/sangre , Infecciones por HTLV-II/diagnóstico , Virus Linfotrópico T Tipo 1 Humano/genética , Virus Linfotrópico T Tipo 1 Humano/inmunología , Virus Linfotrópico T Tipo 2 Humano/genética , Virus Linfotrópico T Tipo 2 Humano/inmunología , Humanos , Reacción en Cadena de la Polimerasa , Embarazo , Complicaciones Infecciosas del Embarazo/diagnóstico , Complicaciones Infecciosas del Embarazo/virología , Diagnóstico Prenatal/estadística & datos numéricos , Prevalencia , Factores de RiesgoRESUMEN
Neste estudo, foi estimada a prevalência da infecção pelo HTLV 1/2 em gestantes no Estado de Mato Grosso do Sul, por meio das técnicas ELISA, Western Blot e PCR, em amostras de sangue obtidas por punção venosa periférica. Foram examinadas 116.689 gestantes, sendo diagnosticadas 153 infectadas pelo HTLV 1/2, com prevalência de 0,13 por cento. Deste total, 133 (86,9 por cento) eram do tipo 1 e 20 (11,1 por cento) do tipo 2. Das 153 gestantes, 73,2 por cento eram negras, pardas ou índias, cerca de 90 por cento tinham atividades domésticas e 75,8 por cento (116/153) tinham 7 anos ou menos de escolaridade. As 153 gestantes tiveram 172 gestações, durante o período do estudo, sendo que 164 tiveram acompanhamento. Das gestações acompanhadas, 6,7 por cento (11/164) evoluíram para aborto, 26,8 por cento (41/153) gestantes relataram abortos anteriores, sendo que 31,7 por cento (13/41) apresentaram mais de dois abortos. Co-morbidades foram detectadas em 17 por cento (26/153) sendo 3,3 por cento (5/153) com HIV (p<0,000002). Os autores enfatizam a importância da identificação das gestantes infectadas pelo HTLV1/2 na estratégia de controle e prevenção da doença.
In this study, the prevalence of HTLV 1/2 infection among pregnant women in the State of Mato Grosso do Sul was estimated by means of the ELISA, Western Blot and PCR techniques, in blood samples collected by peripheral venous puncture. 116,689 pregnant women were examined and 153 were diagnosed as presenting HTLV 1/2 infection, with prevalence of 0.13 percent. Among these 153 pregnant women, 133 (86.9 percent) had type 1 and 20 (11.1 percent) had type 2; 73.2 percent were black, brown or indigenous; about 90 percent performed domestic activities; and 75.8 percent (116/153) had been to school for seven years or less. The 153 pregnant women had 172 pregnancies during the study period and 164 pregnancies were followed. Out of pregnancies that were followed, 6.7 percent (11/164) evolved to abortion, 26.8 percent (41/153) reported previous abortions and 31.7 percent (13/41) had had more than two abortions. Comorbidities were found in 17 percent (26/153), among whom 3.3 percent (5/153) had HIV (p<0.000002). The authors emphasize the importance of identifying pregnant women with HTLV 1/2 infection, as a strategy for disease control and prevention.
Asunto(s)
Adolescente , Adulto , Femenino , Humanos , Embarazo , Infecciones por HTLV-I/epidemiología , Infecciones por HTLV-II/epidemiología , Virus Linfotrópico T Tipo 1 Humano , Complicaciones Infecciosas del Embarazo/epidemiología , Western Blotting , Brasil/epidemiología , Ensayo de Inmunoadsorción Enzimática , Anticuerpos Anti-HTLV-I/sangre , Infecciones por HTLV-I/diagnóstico , Anticuerpos Anti-HTLV-II/sangre , Infecciones por HTLV-II/diagnóstico , Virus Linfotrópico T Tipo 1 Humano/genética , Virus Linfotrópico T Tipo 1 Humano/inmunología , /genética , /inmunología , Reacción en Cadena de la Polimerasa , Prevalencia , Complicaciones Infecciosas del Embarazo/diagnóstico , Complicaciones Infecciosas del Embarazo/virología , Diagnóstico Prenatal/estadística & datos numéricos , Factores de RiesgoRESUMEN
Objetivo: estudar os comportamentos epidemiológicos, virológicos e genotípicos do HTLV-1/2 em gestantes diagnosticadas durante o pré-natal de Mato Grosso do Sul, e em seus filhos, nascidos no período de novembro de 2002 a dezembro de 2005. Metodologia: foram incluídas mulheres atendidas pelo Programa de proteção à Gestante no período de novembro de 2002 a dezembro de 2005 diagnosticadas como infectadas pelo HTLV-1/2 através das técnicas ELISA, Western Blot e PCR. Para definir ou excluir a infecção na criança, foram realizados testes PCR ao nascimento, aos 2 meses e 4 meses de idade; ELISA e Western Blot aos 12 meses e após 18 meses de idade quando não amamentadas. Resultados: foram examinadas 116.689 gestantes sendo diagnosticadas 153 infectadas pelo HTLV 1/2, com prevalência de 0,13%; 73,2% eram negras, pardas ou índias, cerca de 90% tinham atividades domésticas e 75,8% tinham 7 anos ou menos de escolaridade. das gestações acompanhadas 6,7% (11/164) evoluíram para aborto e co-morbidades foram detectadas em 17,0% (26/153) sendo 3,3% (5/153) com HIV (p menor que 0,000002). Foram incluídas 123 crianças nascidas vivas, 5 das quais evoluíram para óbito no primeiro ano de vida e 7 aguardam confirmação do diagnóstico. A infecção foi confirmada em 8 crianças, resultando em uma taxa de transmissão vertical de 7,2% (8/111). Conclusões: não foi observada diferença estatisticamente significativa com relação as variáveis maternas e nas crianças o que pode ser decorrência do pequeno tamanho da amostra estudada. Novos estudos são necessários para se conhecer os fatores de risco para a transmissão vertical do HTLV 1/2; estudos de coorte com protocolos clínicos que procurem observar o possível papel da antigenemia e titulagem de anticorpos maternos durante a gestação, tipo de parto e período de aleitamento. Recomenda-se a implantação da testagem para anti-HTLV 1/2 em todas as mulheres...
Asunto(s)
Humanos , Femenino , Embarazo , Transmisión Vertical de Enfermedad Infecciosa , Infecciones por HTLV-I/epidemiología , Infecciones por HTLV-II/epidemiología , Reacción en Cadena de la Polimerasa , Factores de Riesgo , Brasil , Mujeres EmbarazadasRESUMEN
This prospective study, involving 76 pregnant women infected with HIV, paired with their 79 exposed infants, was carried out between May 1996 and October 2001, at the Reference Department for Pregnant Women Infected with HIV in Campo Grande, Mato Grosso do Sul. The mean age of the pregnant women was 24 years; 88% (67/76) apparently were infected due to sexual practices; 88% (67/76) were housewives; 823% (63/76) graduated from junior high school; 14.5% (11/76) reported co-infection with Hepatitis C, 9.2% with Syphilis; 51% (39/76) learned the diagnosis during prenatal care; 67% (51/76) reported HIV clinical symptomatology and 9.2% (7/76) reported opportunistic infections. Elective cesareans were performed in 57% (43/76). The mean gestational age at delivery was 38 weeks and we found 12.5% (10/80) pronatis; 97% (74/76) had a ruptured membrane time after less than four hours and one child (1.3%) was nursed. ACTG 076 Protocol (AIDS Clinical Trial Group 076) was used in 80% (61/76) of the pregnant women, with 100% adherence; 62% (38/61) used zidovudine plus another antiretroviral in the gestation; 92% (73/79) of the infants used zidovudine after the birth and 19% (14/73) used zidovudine and lamivudine. The transmission rate in this study was 2.5%.
Asunto(s)
Fármacos Anti-VIH/uso terapéutico , Infecciones por VIH/transmisión , Transmisión Vertical de Enfermedad Infecciosa/prevención & control , Complicaciones Infecciosas del Embarazo , Adolescente , Adulto , Brasil/epidemiología , Estudios de Cohortes , Ensayo de Inmunoadsorción Enzimática , Femenino , Estudios de Seguimiento , Infecciones por VIH/diagnóstico , Infecciones por VIH/prevención & control , Humanos , Recién Nacido , Lamivudine/uso terapéutico , Embarazo , Estudios Prospectivos , Factores de Riesgo , Carga Viral , Zidovudina/uso terapéuticoRESUMEN
This prospective study, involving 76 pregnant women infected with HIV, paired with their 79 exposed infants, was carried out between May 1996 and October 2001, at the Reference Department for Pregnant Women Infected with HIV in Campo Grande, Mato Grosso do Sul. The mean age of the pregnant women was 24 years; 88 percent (67/76) apparently were infected due to sexual practices; 88 percent (67/76) were housewives; 823 percent (63/76) graduated from junior high school; 14.5 percent (11/76) reported co-infection with Hepatitis C, 9.2 percent with Syphilis; 51 percent (39/76) learned the diagnosis during prenatal care; 67 percent (51/76) reported HIV clinical symptomatology and 9.2 percent (7/76) reported opportunistic infections. Elective cesareans were performed in 57 percent (43/76). The mean gestational age at delivery was 38 weeks and we found 12.5 percent (10/80) pronatis; 97 percent (74/76) had a ruptured membrane time after less than four hours and one child (1.3 percent) was nursed. ACTG 076 Protocol (AIDS Clinical Trial Group 076) was used in 80 percent (61/76) of the pregnant women, with 100 percent adherence; 62 percent (38/61) used zidovudine plus another antiretroviral in the gestation; 92 percent (73/79) of the infants used zidovudine after the birth and 19 percent (14/73) used zidovudine and lamivudine. The transmission rate in this study was 2.5 percent.